======= MED18 ======= == Gene Information == * **Official Symbol**: MED18 * **Official Name**: mediator complex subunit 18 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=54797|54797]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BUE0|Q9BUE0]] * **Interactions**: [[https://thebiogrid.org/search.php?search=MED18&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MED18|Open PubMed]] * **OMIM**: [[https://omim.org/entry/612384|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. |Med18| |core mediator complex| |termination of RNA polymerase II transcription| |mediator complex| |DNA-templated transcription, termination| |transcription coregulator activity| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|1.73| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.76| ^Gene^Correlation^ |[[:human genes:t:tada1|TADA1]]|0.464| |[[:human genes:m:med16|MED16]]|0.449| |[[:human genes:c:ccdc101|CCDC101]]|0.43| |[[:human genes:m:mad2l1|MAD2L1]]|0.401| Global Fraction of Cell Lines Where Essential: 177/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|13/28| |blood|9/28| |bone|8/25| |breast|11/33| |central nervous system|8/56| |cervix|3/4| |colorectal|5/17| |esophagus|2/13| |fibroblast|0/1| |gastric|3/15| |kidney|4/21| |liver|3/20| |lung|19/75| |lymphocyte|6/14| |ovary|3/26| |pancreas|8/24| |peripheral nervous system|7/16| |plasma cell|7/15| |prostate|0/1| |skin|3/24| |soft tissue|1/7| |thyroid|0/2| |upper aerodigestive|5/22| |urinary tract|4/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1648 * **Expression level (log2 read counts)**: 4.31 {{:chemogenomics:nalm6 dist.png?nolink |}}